Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 27, Issue 12, 2008, Pages 1261-1263

  Power, D A ^a   Burton, J P ^b   Chilcott, C N ^b   Dawes, P J ^a   Tagg, J R ^a,b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b BLIS Technologies Ltd   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; LANTIBIOTIC; PROBIOTIC AGENT;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; HUMAN; HUMAN TISSUE; INFANT; MOUTH CAVITY; NASOPHARYNX; NONHUMAN; OTITIS MEDIA; PRESCHOOL CHILD; PRIORITY JOURNAL; STREPTOCOCCUS SALIVARIUS; TREATMENT DURATION; TREATMENT FAILURE; UPPER RESPIRATORY TRACT;

ADMINISTRATION, ORAL; AMOXICILLIN; CHILD, PRESCHOOL; HUMANS; INFANT; LYMPHOID TISSUE; MOUTH; NASOPHARYNX; PROBIOTICS; RESPIRATORY SYSTEM; STREPTOCOCCUS;

EID: 56349146362     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0569-4     Document Type: Article

References (10)

1. JE Roberts RM Rosenfeld SA Zeisel 2004 Otitis media and speech and language: a meta-analysis of prospective studies Pediatrics 113 e238 e248
2. K Roos EG Håkansson S Holm 2001 Effect of recolonisation with "interfering" alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial BMJ 322 210 212
3. K Roos SE Holm E Grahn-Håkansson L Lagergren 1996 Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis-a randomized placebo-controlled multicentre study Scand J Infect Dis 28 459 462
4. CW Douglas J Heath KK Hampton FE Preston 1993 Identity of viridans streptococci isolated from cases of infective endocarditis J Med Microbiol 39 179 182
5. JP Burton PA Wescombe CJ Moore CN Chilcott JR Tagg 2006 Safety assessment of the oral cavity probiotic Streptococcus salivarius K12 Appl Environ Microbiol 72 3050 3053
6. PA Wescombe JP Burton PA Cadieux NA Klesse O Hyink NC Heng CN Chilcott G Reid JR Tagg 2006 Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius Antonie Van Leeuwenhoek 90 269 280
7. O Hyink PA Wescombe M Upton N Ragland JP Burton JR Tagg 2007 Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12 Appl Environ Microbiol 73 1107 1113
8. JR Tagg V Pybus LV Phillips TM Fiddes 1983 Application of inhibitor typing in a study of the transmission and retention in the human mouth of the bacterium Streptococcus salivarius Arch Oral Biol 28 911 915
9. FJ de Bruijn 1992 Use of repetitive (repetitive extragenic palindromic and enterobacterial repetitive intergeneric consensus) sequences and the polymerase chain reaction to fingerprint the genomes of Rhizobium meliloti isolates and other soil bacteria Appl Environ Microbiol 58 2180 2187
10. KP Dierksen CJ Moore M Inglis PA Wescombe JR Tagg 2007 The effect of ingestion of milk supplemented with salivaricin A-producing Streptococcus salivarius on the bacteriocin-like inhibitory activity of streptococcal populations on the tongue FEMS Microbiol Ecol 59 584 591